BCLI
BRAINSTORM CELL THERAPUTC
BCLI
BCLI
Delisted
BCLI was delisted on the 17th of July, 2025.
76 hedge funds and large institutions have $70M invested in BRAINSTORM CELL THERAPUTC in 2020 Q2 according to their latest regulatory filings, with 33 funds opening new positions, 20 increasing their positions, 12 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
0.51% more ownership
Funds ownership: 0.9% → 1.41% (+0.51%)
76% less call options, than puts
Call options by funds: $9.36M | Put options by funds: $38.3M
Holders
76
Holding in Top 10
–
Calls
$9.36M
Puts
$38.3M
Top Buyers
| 1 | +$16.5M | |
| 2 | +$4.74M | |
| 3 | +$2.51M | |
| 4 |
AHB
Abner Herrman & Brock
Jersey City,
New Jersey
|
+$2.05M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.57M |
Top Sellers
| 1 | -$4.88M | |
| 2 | -$2.06M | |
| 3 | -$721K | |
| 4 |
EI
EAM Investors
Solana Beach,
California
|
-$539K |
| 5 |
EMG
ETF Managers Group
Summit,
New Jersey
|
-$155K |